
NVIDIA's BioNeMo Bets Big on AI Foundation Models as the New Lab Infrastructure
NVIDIA is positioning its BioNeMo platform as the foundational compute layer for pharmaceutical R&D, backed by partnerships with Thermo Fisher and Eli Lilly. A concurrent surge of specialized biotech AI models from startups and established players signals that AI foundation models are rapidly becoming standard infrastructure in drug discovery pipelines.


